par Nelson, Mark;Amaya, Gerardo;Clumeck, Nathan ;Arns da cunha, Clovis;Jayaweera, Dushyantha;Junod, Patrice;Li, Taisheng;Tebas, Pablo;Stevens, Marita;Buelens, Annemie;Vanveggel, Simon;Boven, Katia;Abusamra, Lorena;Cahn, Pedro;Laplume, Héctor;Cassetti, Isabel;Ceriotto, Mariana;Martins, M.D.;Krolewiecki, Alejandro;Amarilis Lugo, L.;Bolan, Robert;Bush, Larry Marc;Corales, Roberto Baun;Crane, Lawrence Richard;De Vente, J.;Fischl, Margaret A.;Gathe, Joseph;Greenberg, Richard;Henry, Kenneth;Jayaweera, D.;Kumar, Princy Suresh;Lalezari, Jacob;Leider, Jason;Lubelchek, Ronald Jay;Martorell, Claudia;Mounzer, Karam;Cohen, Calvin;Olivet, Hannah;Ortiz, Reinaldo;Rhame, Frank;Roberts, Afsoon;Ruane, Peter;Scribner, Anita;Segal-Maurer, Sorana;Short, William;Sloan, Louis;Wilkin, Timothy;Wohlfeiler, Michael;Yangco, Bienvenido
Référence Journal of antimicrobial chemotherapy, 67, 8, page (2020-2028), dks130
Publication Publié, 2012-08
Référence Journal of antimicrobial chemotherapy, 67, 8, page (2020-2028), dks130
Publication Publié, 2012-08
Article révisé par les pairs
Titre: |
|
Auteur: | Nelson, Mark; Amaya, Gerardo; Clumeck, Nathan; Arns da cunha, Clovis; Jayaweera, Dushyantha; Junod, Patrice; Li, Taisheng; Tebas, Pablo; Stevens, Marita; Buelens, Annemie; Vanveggel, Simon; Boven, Katia; Abusamra, Lorena; Cahn, Pedro; Laplume, Héctor; Cassetti, Isabel; Ceriotto, Mariana; Martins, M.D.; Krolewiecki, Alejandro; Amarilis Lugo, L.; Bolan, Robert; Bush, Larry Marc; Corales, Roberto Baun; Crane, Lawrence Richard; De Vente, J.; Fischl, Margaret A.; Gathe, Joseph; Greenberg, Richard; Henry, Kenneth; Jayaweera, D.; Kumar, Princy Suresh; Lalezari, Jacob; Leider, Jason; Lubelchek, Ronald Jay; Martorell, Claudia; Mounzer, Karam; Cohen, Calvin; Olivet, Hannah; Ortiz, Reinaldo; Rhame, Frank; Roberts, Afsoon; Ruane, Peter; Scribner, Anita; Segal-Maurer, Sorana; Short, William; Sloan, Louis; Wilkin, Timothy; Wohlfeiler, Michael; Yangco, Bienvenido |
Informations sur la publication: | Journal of antimicrobial chemotherapy, 67, 8, page (2020-2028), dks130 |
Statut de publication: | Publié, 2012-08 |
Sujet CREF: | Pharmacologie |
Pathologie maladies infectieuses | |
Mots-clés: | Efavirenz |
HBV | |
HCV | |
Hepatic safety | |
Hepatitis | |
Non-nucleoside reverse transcriptase inhibitors | |
TMC278 | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0305-7453 |
info:doi/10.1093/jac/dks130 | |
info:scp/84864505008 | |
info:pmid/22532465 |